Cytosorbents (CTSO) Return on Capital Employed (2011 - 2026)
Cytosorbents posted quarterly Return on Capital Employed of 53.34% for Q1 2026, down 1348.0% year-on-year from 4.27% in Q1 2025, and down 27.51% on a QoQ basis from 41.84% in Q4 2025.
Cytosorbents (CTSO) has 15 years of Return on Capital Employed data on file, last reported at 53.34% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 1348.0% year-over-year to 53.34%; the trailing twelve-month figure through Mar 2026 stood at 53.34% (down 1348.0% YoY), and the FY2025 full-year result was 40.89%, down 11.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 53.34%, down from 41.84% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 37.43% in Q3 2025 and bottomed at 86.14% in Q4 2023.
- The 5-year median for Return on Capital Employed is 53.34% (2026), against an average of 55.27%.
- The widest annual swing landed in 2022, when Return on Capital Employed slumped 4285 bps; it then surged 4258 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 59.43% in 2022, then slumped by 45 bps to 86.14% in 2023, then surged by 49 bps to 43.56% in 2024, then rose by 4 bps to 41.84% in 2025, then decreased by 28 bps to 53.34% in 2026.
- The last three Return on Capital Employed figures came in at 53.34% (Q1 2026), 41.84% (Q4 2025), and 37.43% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | -53.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.34% |
| Dec 31, 2025 | -41.84% |
| Sep 30, 2025 | -37.43% |
| Jun 30, 2025 | -39.77% |
| Mar 31, 2025 | -39.86% |
| Dec 31, 2024 | -43.56% |
| Sep 30, 2024 | -53.07% |
| Jun 30, 2024 | -61.53% |
| Mar 31, 2024 | -75.02% |
| Dec 31, 2023 | -86.14% |
| Sep 30, 2023 | -73.45% |
| Jun 30, 2023 | -66.32% |
| Mar 31, 2023 | -62.13% |
| Dec 31, 2022 | -59.43% |
| Sep 30, 2022 | -61.34% |
| Jun 30, 2022 | -46.66% |
| Mar 31, 2022 | -38.60% |
| Dec 31, 2021 | -28.94% |
| Sep 30, 2021 | -18.49% |
| Jun 30, 2021 | -15.08% |
| Mar 31, 2021 | -13.61% |
| Dec 31, 2020 | -11.92% |
| Sep 30, 2020 | -22.16% |
| Jun 30, 2020 | -54.17% |
| Mar 31, 2020 | -70.53% |
| Dec 31, 2019 | -104.85% |
| Sep 30, 2019 | -99.21% |
| Jun 30, 2019 | -71.04% |
| Mar 31, 2019 | -64.78% |
| Dec 31, 2018 | -57.07% |
| Sep 30, 2018 | -45.51% |
| Jun 30, 2018 | -47.07% |
| Mar 31, 2018 | -51.25% |
| Dec 31, 2017 | -64.28% |
| Sep 30, 2017 | -64.78% |
| Jun 30, 2017 | -118.37% |
| Mar 31, 2017 | -390.22% |
| Dec 31, 2016 | -191.61% |
| Sep 30, 2016 | -134.65% |
| Jun 30, 2016 | -127.35% |
| Mar 31, 2016 | -121.69% |
| Dec 31, 2014 | -151.75% |
| Sep 30, 2014 | -56.29% |
| Jun 30, 2014 | -48.61% |
| Mar 31, 2014 | -90.34% |
| Dec 31, 2013 | -482.20% |
| Sep 30, 2013 | -1,017.77% |
| Jun 30, 2013 | -652.94% |
| Mar 31, 2013 | -198.28% |
| Dec 31, 2012 | -284.48% |
| Sep 30, 2012 | -362.29% |
| Jun 30, 2012 | -796.93% |
| Mar 31, 2012 | -2,139.56% |
| Dec 31, 2011 | -443.44% |
| Sep 30, 2011 | -217.88% |